{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:11:32Z","timestamp":1788757892784,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although central nervous system leukemia (CNSL) is a recognized complication of acute leukemia, myelodysplastic neoplasms (MDS) complicated by CNSL are exceedingly rare, particularly after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous studies have largely focused on chronic myelomonocytic leukemia with central nervous system (CNS) involvement. Here, we describe the first comprehensively documented case of isolated CNS infiltration after allo-HSCT in a patient with MDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A patient with high-risk MDS with increased blasts-2, harboring\n                      <jats:italic>IDH1<\/jats:italic>\n                      and\n                      <jats:italic>TP53<\/jats:italic>\n                      mutations, a complex karyotype, and a very high Molecular International Prognostic Scoring System score underwent unrelated allo-HSCT. On day +19 post-transplantation, the patient developed a severe, unexplained headache. Cerebrospinal fluid (CSF) analysis by flow cytometry revealed blasts largely immunophenotypically consistent with those in the bone marrow at initial diagnosis, while concurrent bone marrow assessment confirmed remission. CSF blasts were cleared following triple intrathecal therapy (IT). To date, the patient remains in remission on azacitidine maintenance therapy, with an overall survival of 14 months from diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although CNSL is exceptionally rare in patients with MDS, this case demonstrates that isolated CNS infiltration may occur after allo-HSCT. Our findings emphasize that CNS involvement should be considered in the differential diagnosis of patients with MDS presenting with neurological manifestations, even without marrow relapse. Furthermore, this case highlights the critical role of CSF flow cytometry in establishing the diagnosis when conventional CSF studies are inconclusive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1916682","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:23:39Z","timestamp":1788755019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Central nervous system infiltration after allogeneic hematopoietic stem cell transplantation in high-risk myelodysplastic neoplasms"],"prefix":"10.3389","volume":"16","author":[{"given":"Lejian","family":"Shi","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Zhu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanle","family":"Gong","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University","place":["Suzhou, China"]},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40164-025-00678-9","article-title":"Advances and challenges in the treatment of myelodysplastic syndromes","volume":"14","author":"Thalla","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40164-025-00652-5","article-title":"Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study","volume":"14","author":"Zugasti","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn121090-20251205-00574","article-title":"Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)","volume":"47","year":"2026","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3960\/jslrt1961.24.95","article-title":"Four cases of chronic myelomonocytic leukemia","volume":"24","author":"Umezumi","year":"1984","journal-title":"Journal of the Japan Society of the Reticuloendothelial System"},{"key":"B5","article-title":"Meningeal leukemia in the chronic stage of chronic myelomonocytic leukemia","volume":"29","author":"Ohno","year":"1988","journal-title":"Rinsho Ketsueki"},{"key":"B6","article-title":"A 45-year-old man with peripheral monocytosis and right hemiparesis","volume":"50","author":"Takubo","year":"1998","journal-title":"No To Shinkei"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1138-5","article-title":"Meningeal involvement of chronic myelomonocytic leukemia","volume":"250","author":"Aoyama","year":"2003","journal-title":"J Neurol"},{"key":"B8","unstructured":"Meningeal infiltration of chronic myelomonocytic leukemia\n          \n          \n            \n              Ostojic\n              IMRS\n            \n          \n          \n          2014"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7192","article-title":"Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1422866","article-title":"Chronic myelomonocytic leukemia with central nervous system involvement","volume":"59","author":"Hannon","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1464391","article-title":"Chronic subdural collection overlying an intra-axial hemorrhagic lesion in chronic myelomonocytic leukemia: special report and review of the literature","volume":"18","author":"Bernat","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_344_20","article-title":"Isolated CNS relapse in FLT 3 mutation positive CMML post allogeneic stem cell transplant: Report of a rare case","volume":"64","author":"Mutreja","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13256-021-02947-7","article-title":"Cerebral localization of chronic myelomonocytic leukemia: a case report","volume":"15","author":"Ham\u00e9on","year":"2021","journal-title":"J Med Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.740","article-title":"Cerebral localization of chronic myelomonocytic leukemia and improvement with high\u2010dose cytarabine: A case report","volume":"4","author":"Ham\u00e9on","year":"2023","journal-title":"EJHaem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.59.2583","article-title":"Young adult myelodysplastic syndrome with central nervous system involvement diagnosed following cerebral embolism","volume":"59","author":"Sato","year":"2018","journal-title":"Rinsho Ketsueki"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.165.3.7645483","article-title":"Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases","volume":"165","author":"Schwartz","year":"1995","journal-title":"Am J Roentgenol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12245-026-01138-9","article-title":"Posterior reversible encephalopathy syndrome (PRES): A narrative review of pathophysiology, clinical insights, and advances in management","volume":"19","author":"Mourid","year":"2026","journal-title":"Int J Emerg Med"},{"key":"B19","unstructured":"WHO Guidelines on Meningitis Diagnosis, Treatment and Care\n          \n          \n          Geneva\n          \n          2025"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-2727.2022.09.002","article-title":"Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)","volume":"43","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221117532","article-title":"A case of central nervous system post-transplant lymphoproliferative disorder following haploidentical stem cell transplantation in a patient with acute lymphoblastic leukemia","volume":"31","author":"Zhu","year":"2022","journal-title":"Cell Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition (ICHD-3)","volume":"38","author":"Olesen","year":"2018","journal-title":"Cephalalgia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0145-2126(00)00093-x","article-title":"Human CD38: a (r)evolutionary story of enzymes and receptors","volume":"25","author":"Deaglio","year":"2001","journal-title":"Leuk Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700918","article-title":"Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation","volume":"20","author":"Hibi","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01220-4","article-title":"Central nervous system involvement in adults with acute leukemia: Diagnosis, prevention, and management","volume":"24","author":"Paul","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115970","article-title":"Metabolic and epigenetic dysregulation in IDH1\/2-mutant gliomas: A microglial-mediated mechanism of blood-brain barrier disruption","volume":"169","author":"Pan","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-025-02511-7","article-title":"Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromes","volume":"60","author":"Zhou","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02672-w","article-title":"Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms","volume":"39","author":"Zhao","year":"2025","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025464","article-title":"Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes","volume":"145","author":"Garcia","year":"2025","journal-title":"Blood"},{"key":"B30","unstructured":"Acute Myeloid Leukemia, Version 5.2026\n          \n          \n          \n          2026"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-025-00392-9","article-title":"The utility of stereotactic biopsy of intracranial lesions in the diagnosis of leukemia complicated by central nervous system lesions","volume":"11","author":"Wu","year":"2025","journal-title":"Chin Neurosurg J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042960","article-title":"Central nervous system involvement at first relapse in patients with acute myeloid leukemia","volume":"96","author":"Mart\u00ednez-Cuadr\u00f3n","year":"2011","journal-title":"Haematologica"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1691199","article-title":"Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis","volume":"61","author":"Reid","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000162","article-title":"Diagnosis and management of adult central nervous system leukemia","volume":"5","author":"Liu","year":"2023","journal-title":"Blood Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0274","article-title":"Central nervous system complications after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Chaudhary","year":"2017","journal-title":"Future Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20160120","article-title":"Higher positive identification of Malignant CSF cells using the cytocentrifuge than the Suta chamber","volume":"74","author":"Almeida","year":"2016","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1916682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:23:43Z","timestamp":1788755023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1916682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":37,"alternative-id":["10.3389\/fonc.2026.1916682"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1916682","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1916682"}}